LONDON (Reuters) - European shares fell on Thursday in early deals, weighed down by a drop among healthcare stocks after U.S. President-Elect Donald Trump targeted pharmaceuticals' drug pricing in a press conference.
The pan-European STOXX 600 (STOXX) index was down 0.5 percent, and Europe's healthcare sector index (SXDP) dropped 1.6 percent, the biggest sectoral faller.
Donald Trump on Wednesday commented on the need for competitive drug pricing, saying pharmaceutical companies were "getting away with murder" by charging high drug prices.
Swiss luxury goods group Richemont (S:CFR) was the top European gainer, jumping 8 percent after its trading update indicated a pick-up in demand for watches and jewellery. Shares in peer Swatch Group (S:UHR) also rose 5.4 percent.
Britain's blue-chip FTSE 100 (FTSE) was down 0.3 percent, with retailers Tesco (L:TSCO) and AB Foods (L:ABF) top fallers after they reported results.